Table 4.
Treatments¹ |
P-value |
||||||||
---|---|---|---|---|---|---|---|---|---|
Item | NC | PC | 500 | 1,000 | 1,500 | SEM11 | ANOVA | Linear | Quadratic |
UA2 (mg/DL) | 3.64 | 3.53 | 3.40 | 3.16 | 3.23 | 0.79 | 0.137 | 0.122 | 0.335 |
Alt3 (IU/L) | 9.81 | 11.69 | 9.62 | 10.11 | 9.92 | 0.43 | 0.648 | 0.330 | 0.454 |
Albumin (g/L) | 16.42 | 16.75 | 16.13 | 16.81 | 16.44 | 0.21 | 0.839 | 0.901 | 0.969 |
Ast4 (IU/L) | 463.68 | 498.23 | 458.97 | 499.51 | 442.86 | 15.63 | 0.723 | 0.430 | 0.803 |
Cho5 (mg/DL) | 119.71 | 123.72 | 123.47 | 127.34 | 125.90 | 2.28 | 0.863 | 0.271 | 0.659 |
Crea6 (m/ DL) | 0.13 | 0.13 | 0.13 | 0.13 | 0.12 | 0.01 | 0.936 | 0.721 | 0.200 |
Ggt7,12 (IU/L) | 13.68 | 13.08 | 12.92 | 13.39 | 14.45 | 0.54 | 0.910 | 0.142 | 0.011 |
Glu8 (mg/DL) | 260.64 | 254.19 | 264.36 | 250.52 | 260.83 | 2.42 | 0.375 | 0.875 | 0.992 |
TP9 (g/L) | 29.48 | 29.41 | 29.51 | 30.25 | 29.39 | 0.35 | 0.932 | 0.786 | 0.705 |
Trig10(m/DL) | 70.51 | 74.37 | 70.09 | 60.96 | 64.43 | 2.93 | 0.617 | 0.154 | 0.379 |
Urea13 (mg/DL) | 3.32 | 3.86 | 3.91 | 3.75 | 3.37 | 0.16 | 0.669 | 0.141 | 0.011 |
NC – Control diet, without growth promoter antimicrobials; PC – Control diet, added 0.12g/ton of Enramycin (8%); 500 - Control diet, added 500 g/ton of Viligen; 1,000 - Control diet, added 1,000 g/ton of Viligen; 1,500 - Control diet, added 1,500 g/ton of Viligen.
Uric Acid.
Alanine Amino transferase.
Aspartate Amino Transferase.
Cholesterol.
Creatinine.
Gama GT
Glucose.
Total protein.
Triglycerides.
SEM = Standard error of the mean.
Quadractic effect (P < 0.05) of the treatments on the GGT (y = 1.223x2 – 0.9187x + 13.079 R² = 0.9999)
Quadractic effect (P < 0.05) of the treatments on the UREA (y = -0.4341x2 + 0.3252x + 3.8579
R² = 0.9999).